Related Experiment Video
Updated: May 11, 2026

Hepatic Glucose Production, Ureagenesis, and Lipolysis Quantified using the Perfused Mouse Liver Model
Published on: October 6, 2023
[Diabetes in liver cirrhosis]
Diego García-Compeán1, Joel O Jáquez-Quintana, José A González-González
1Servicio de Gastroenterología y Departamento de Medicina Interna, Hospital Universitario Dr. José E. González, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, México. digarciacompean@prodigy.net.mx
Diabetes mellitus (DM) affects up to 90% of liver cirrhosis patients, complicating treatment and outcomes. Research is needed on effective DM management in cirrhosis and its effect on liver disease progression.
Area of Science:
- Endocrinology
- Hepatology
- Metabolic disorders
Context:
- Liver cirrhosis is frequently associated with diabetes mellitus (DM), affecting up to 30% overtly and 90% with impaired glucose tolerance.
- The relationship between DM and cirrhosis is bidirectional, with Type 2 DM potentially causing cirrhosis and DM being a complication of liver disease, termed 'hepatogenous diabetes'.
- Both overt and subclinical DM correlate with increased liver complications and mortality in cirrhotic individuals.
Purpose:
- To highlight the high prevalence of diabetes mellitus in liver cirrhosis.
- To underscore the challenges in treating diabetes in cirrhotic patients due to metabolic disturbances.
- To identify the knowledge gap regarding the impact of glycemic control on liver disease progression.
Summary:
- Diabetes mellitus (DM) is highly prevalent in liver cirrhosis, with impaired glucose tolerance observed in 90% of patients.
- Hepatogenous diabetes, a form of DM secondary to cirrhosis, presents significant treatment challenges due to metabolic impairments.
- The association of DM with liver complications and mortality, and the unknown effects of glycemic control on liver disease, are critical concerns.
Impact:
- Informs clinicians about the high comorbidity of DM in liver cirrhosis.
- Underscores the need for research into effective diabetes management strategies for cirrhotic patients.
- Emphasizes the potential link between glycemic control and liver disease outcomes, warranting further investigation.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Chronic Pancreatitis II: Pathophysiology

